Clinical Trial Update: A Prophylactic Trial of Omega-3 Polyunsaturated Fatty Acids in Bipolar Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial update on prophylactic omega-3 fatty acids in bipolar depression; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression

Drugs mentioned

• Omega-3 polyunsaturated fatty acids (omega-3 polyunsaturated fatty acids)

Snippet

Sponsor: National University of Ireland, Galway, Ireland | Conditions: Bipolar Depression | Phase 2 | Status: COMPLETED